These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 30551481)

  • 21. Beneficial action of resveratrol: How and why?
    Diaz-Gerevini GT; Repossi G; Dain A; Tarres MC; Das UN; Eynard AR
    Nutrition; 2016 Feb; 32(2):174-8. PubMed ID: 26706021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The therapeutic potential of resveratrol: a review of clinical trials.
    Berman AY; Motechin RA; Wiesenfeld MY; Holz MK
    NPJ Precis Oncol; 2017; 1():. PubMed ID: 28989978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol.
    Malhotra A; Bath S; Elbarbry F
    Oxid Med Cell Longev; 2015; 2015():803971. PubMed ID: 26180596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resveratrol and liver disease: from bench to bedside and community.
    Bishayee A; Darvesh AS; Politis T; McGory R
    Liver Int; 2010 Sep; 30(8):1103-14. PubMed ID: 20557453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease.
    Lim KG; Gray AI; Anthony NG; Mackay SP; Pyne S; Pyne NJ
    Arch Toxicol; 2014 Dec; 88(12):2213-32. PubMed ID: 25344023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans.
    Gambini J; Inglés M; Olaso G; Lopez-Grueso R; Bonet-Costa V; Gimeno-Mallench L; Mas-Bargues C; Abdelaziz KM; Gomez-Cabrera MC; Vina J; Borras C
    Oxid Med Cell Longev; 2015; 2015():837042. PubMed ID: 26221416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common pathways in health benefit properties of RSV in cardiovascular diseases, cancers and degenerative pathologies.
    Aires V; Delmas D
    Curr Pharm Biotechnol; 2015; 16(3):219-44. PubMed ID: 25601605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the multimodal health-promoting properties of resveratrol: A comprehensive review.
    Faisal Z; Mazhar A; Batool SA; Akram N; Hassan M; Khan MU; Afzaal M; Hassan UU; Shah YA; Desta DT
    Food Sci Nutr; 2024 Apr; 12(4):2240-2258. PubMed ID: 38628180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resveratrol loaded nanoparticles attenuate cognitive impairment and inflammatory markers in PTZ-induced kindled mice.
    Siddiqui MA; Akhter J; Aarzoo ; Junaid Bashir D; Manzoor S; Rastogi S; Arora I; Aggarwal NB; Samim M
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108287. PubMed ID: 34731689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification.
    Li QS; Li Y; Deora GS; Ruan BF
    Mini Rev Med Chem; 2019; 19(10):809-825. PubMed ID: 30686253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health Effects of Resveratrol: Results from Human Intervention Trials.
    Ramírez-Garza SL; Laveriano-Santos EP; Marhuenda-Muñoz M; Storniolo CE; Tresserra-Rimbau A; Vallverdú-Queralt A; Lamuela-Raventós RM
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update.
    Ghosh S; Banerjee S; Sil PC
    Food Chem Toxicol; 2015 Sep; 83():111-24. PubMed ID: 26066364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol and cardiovascular system-the unfulfilled hopes.
    Chudzińska M; Rogowicz D; Wołowiec Ł; Banach J; Sielski S; Bujak R; Sinkiewicz A; Grześk G
    Ir J Med Sci; 2021 Aug; 190(3):981-986. PubMed ID: 33219913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol, obesity and diabetes.
    Szkudelska K; Szkudelski T
    Eur J Pharmacol; 2010 Jun; 635(1-3):1-8. PubMed ID: 20303945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances of resveratrol in nanostructured based delivery systems and in the management of HIV/AIDS.
    Singh G; Pai RS
    J Control Release; 2014 Nov; 194():178-88. PubMed ID: 25217813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Resveratrol in Pharmaceutical Chemistry].
    Orgován G; Noszál B
    Acta Pharm Hung; 2015; 85(4):123-9. PubMed ID: 26964400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Resveratrol in Cancer Therapy.
    Ko JH; Sethi G; Um JY; Shanmugam MK; Arfuso F; Kumar AP; Bishayee A; Ahn KS
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194365
    [No Abstract]   [Full Text] [Related]  

  • 38. Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and *NO bioavailability: Potential benefits to cardiovascular diseases.
    Frombaum M; Le Clanche S; Bonnefont-Rousselot D; Borderie D
    Biochimie; 2012 Feb; 94(2):269-76. PubMed ID: 22133615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport, stability, and biological activity of resveratrol.
    Delmas D; Aires V; Limagne E; Dutartre P; Mazué F; Ghiringhelli F; Latruffe N
    Ann N Y Acad Sci; 2011 Jan; 1215():48-59. PubMed ID: 21261641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of resveratrol: What formulation solutions to bioavailability limitations?
    Amri A; Chaumeil JC; Sfar S; Charrueau C
    J Control Release; 2012 Mar; 158(2):182-93. PubMed ID: 21978644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.